405% Year-over-Year Revenue Growth in Q4, Reflecting Only 3.5 Weeks of ALPS Operations Consolidated
Preliminary 277% Sequential Growth for Q1 2022 and 2,653% Growth Over Q1 2021
Pre-Tax Profit of $3.0 million in Q4 FY 2021 vs. Pre-Tax loss of $19.4 million in Q3 FY 2021 and $10.6 million in Q4 FY 2020.
Company Continues to Execute at Rapid Pace with Multiple Transactions, Partnerships and New Market Entries
Conference Call on Monday, August 30, 2021 at 11:00 AM ET
LAS VEGAS, Aug. 26, 2021 /PRNewswire/ – Australis Capital Inc. (CSE: AUSA) (OTC: AUSAF) (“AUSA” or the “Company”), doing business as AUDACIOUS, today announced that the Company has filed its financials and management discussion and analysis for the fourth quarter and full year fiscal 2021, the period ending March 31, 2021.
The Company earned pre-tax net income of $3.0 million in Q4 FY 2021 compared to pre-tax losses of $19.4 million in Q3 FY 2021 and $10.6 million in Q4 FY 2020. The Company benefited from increases in value in its Body and Mind (“BaM”) holdings, favorable legacy settlements and cost reductions led by the new management team and other revaluations. These management efforts led to reductions of 16% in adjusted EBITDA losses for Q4 FY 2021 compared to Q4 FY 2020 and 22% for FY 2021 over FY 2020.
The acquisition of ALPS more than doubled revenues for all of FY 2021 even though the Company only owned ALPS for the last 23 days of the fiscal year. Green Therapeutics (“GT”) was acquired towards the end of fiscal 2021 and will contribute more substantially to revenues in FY 2022 once the licenses are transferred over to complete the balance of the acquisition. On a pro forma basis, assuming ALPS and GT were both consolidated from January 1, 2021, revenues